Curative Labs Inc

1700 Royston Ln, Suite B

Round Rock, TX 78664
support@curative.com
Final Results
Report

Patient Name: Vera, Angel Facility: Texas Curative Testing

Patient MRN: CUR136766756 Requisition: 48019472

Date of Birth: 2008-09-13 (13 years old) Kit ID: A986993446942

Sex: male Collected: 10/15/21 09:05:10 AM CDT

Address: 8328 N 26th St McAllen, TX 78504 Received: 10/16/21 09:54:29 AM CDT

Phone Number: 19565632034 Released: 10/16/21 06:53:02 PM CDT

Email: viryangel21@hotmail.com Specimen Type: Alinity shallow nasal swab

Physician: Zalzala, Sajad

(1639311509)

Test Result

SARS-CoV-2 Assay (RNA Detection Test by RT-qPCR) Negative

Interpretation:

Positive: SARS-CoV-2 RNA detected by RT-qPCR

Negative: SARS-CoV-2 RNA not detected by RT-qPCR
Indeterminate: Indeterminate for SARS-CoV-2 RNA by RT-qPCR.

Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical

correlation with patient history and other diagnostic information is
necessary
to determine patient infection status. Positive results do not
rule out bacterial infection or co-infection with other viruses. The agent
detected may not be
the definite cause of disease. Laboratories within the
United States and its territories are required to report all positive
results to the appropriate public
health authorities.

Negative results do not preclude SARS-CoV-2 infection and should not be used
as the sole basis for patient management decisions. Inadequate sample
collection or exposure to extreme heat during transport may decrease the
ability to detect SARS-CoV-2 RNA in a sample. Negative results must be
combined with clinical observations, patient history, and epidemiological
information.

Indeterminate results may occur in the case of an inadequate specimen such

as quantity not sufficient. Specimen must be recollected if test is still
required.

Method: Real-Time Reverse-Transcription PCR

This test is based on the CDC SARS-CoV-2 assay, a real-time

reverse-transcription polymerase chain reaction (RT-PCR) test that detects
RNA from
SARS-CoV-2 in upper or lower respiratory specimens. The test has
been optimized to be performed on the BioRad CFX Real-Time PCR detection
system
and uses high throughput technologies.

Disclaimer:

This SARS-CoV-2 PCR test was developed and its performance characteristics
were determined by Curative Labs. This test has not been cleared,
approved
or authorized by the U.S. Food and Drug Administration (FDA). This test may
be used for clinical purposes and should not be regarded as
investigational
or for research only. Curative Laboratory is certified under the Clinical
Laboratory Improvement Amendments of 1988 (CLIA) as qualified to
perform
high complexity clinical laboratory testing. The results are not intended to
be used as the sole means for clinical diagnosis or patient management
decisions.

Lab director: Arthur Baca, MD PhD; CLIA # 45D2192800; Sample

reviewed at: 10/16/21 06:23:02 PM CDT; Report generated at:
10/16/21 06:54:15 PM
CDT